Key points are not available for this paper at this time.
. We envision that our work can be used as a risk assessment tool for patients diagnosed with IPMNs and facilitate greater understanding and investigation of the cellular interactions that cause transition of IPMNs to PDAC.
Barua et al. (Mon,) studied this question.